Home > Result Summaries: Compounds > GSK2330672 Result Summaries: GSK2330672 GSKStudy ID Phase Title Summary (Download) 114985 phase 1 A first time in human, single blind, randomized, placebo-controlled,dose escalating crossover study to evaluate the safety,tolerability, pharmacokinetic and pharmacodynamic parameters of single doses of GSK2330672 in healthy volunteers (0 citation(s))
